BRIT J CLIN PHARMACO

Publications

  1. 2023
  2. COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort

    Favre, G., Gerbier, E., Maisonneuve, E., Pomar, L., Winterfeld, U., Lepigeon, K., Bloemenkamp, K. W. M., de Bruin, O., Eimir, H., Nordeng, H., Siiskonen, S. J., Sturkenboom, M. C. J. M., Baud, D., Panchaud, A. & COVI-PREG and CONSIGN group, 05.2023, In: BRIT J CLIN PHARMACO. 89, 5, p. 1560-1574 15 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2020
  4. Metamizole: An underrated agent causing severe idiosyncratic drug-induced liver injury

    Sebode, M., Reike-Kunze, M., Weidemann, S., Zenouzi, R., Hartl, J., Peiseler, M., Liwinski, T., Schulz, L., Weiler-Normann, C., Sterneck, M., Lohse, A. W. & Schramm, C., 07.2020, In: BRIT J CLIN PHARMACO. 86, 7, p. 1406-1415 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. 2017
  6. Pharmacokinetics of tranexamic acid in neonates and infants undergoing cardiac surgery

    Gertler, R., Gruber, M., Grassin-Delyle, S., Urien, S., Martin, K., Tassani-Prell, P., Braun, S., Burg, S. & Wiesner, G., 08.2017, In: BRIT J CLIN PHARMACO. 83, 8, p. 1745-1757 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. 2016
  8. Oral supplementation with L-homoarginine in young volunteers

    Atzler, D., Schönhoff, M., Cordts, K., Ortland, I., Hoppe, J., Hummel, F. C., Gerloff, C., Jaehde, U., Jagodzinski, A., Böger, R. H., Choe, C-U. & Schwedhelm, E., 12.2016, In: BRIT J CLIN PHARMACO. 82, 6, p. 1477-1485

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis

    Johansson, T., Abuzahra, M. E., Keller, S., Mann, E., Faller, B., Sommerauer, C., Höck, J., Löffler, C., Köchling, A., Schuler, J., Flamm, M. & Sönnichsen, A., 08.2016, In: BRIT J CLIN PHARMACO. 82, 2, p. 532-48 17 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  10. 2015
  11. The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients

    Bachmann, H. S., Meier, W., du Bois, A., Kimmig, R., Kuhlmann, J. D., Siffert, W., Sehouli, J., Wollschlaeger, K., Huober, J., Hillemanns, P., Burges, A., Schmalfeldt, B., Aminossadati, B. & Wimberger, P., 11.2015, In: BRIT J CLIN PHARMACO. 80, 5, p. 1139-48 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. 2013
  13. Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters

    Grün, B., Kiessling, M. K., Burhenne, J., Riedel, K-D., Weiss, J., Rauch, G., Haefeli, W. E. & Czock, D., 11.2013, In: BRIT J CLIN PHARMACO. 76, 5, p. 787-796 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. 2008
  15. Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure

    Albers, S., Meibohm, B., Mir, T. S. & Läer, S., 04.2008, In: BRIT J CLIN PHARMACO. 65, 4, p. 511-522 12 p., 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease.

    Bierend, A., Rau, T., Maas, R., Schwedhelm, E. & Böger, R., 2008, In: BRIT J CLIN PHARMACO. 65, 4, p. 540-547 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism.

    Schwedhelm, E., Maas, R., Freese, R., Jung, D., Lukacs, Z., Jambrecina, A., Spickler, W., Schulze, F. & Böger, R., 2008, In: BRIT J CLIN PHARMACO. 65, 1, p. 51-59 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. 2007
  19. Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.

    Kom, G. D., Schwedhelm, E., Maas, R., Schneider, L., Benndorf, R. & Böger, R., 2007, In: BRIT J CLIN PHARMACO. 63, 6, p. 672-679 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. 2005
  21. Bioavailability of diclofenac potassium at low doses.

    Hinz, B., Chevts, J., Renner, B., Wuttke, H., Rau, T., Schmidt, A., Szelenyi, I., Brune, K. & Werner, U., 2005, In: BRIT J CLIN PHARMACO. 59, 1, p. 80-84 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. 2000
  23. Nebivolol decreases systemic oxidative stress in healthy volunteers.

    Troost, R., Schwedhelm, E., Rojczyk, S., Tsikas, D. & Frölich, J. C., 2000, In: BRIT J CLIN PHARMACO. 50, 4, p. 377-379 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review